|
DHX35 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.53629994784177E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.64110000039553E-07 |
| Normal-vs-Stage2 |
1.239100E-03 |
| Normal-vs-Stage3 |
1.7390000000006E-06 |
| Normal-vs-Stage4 |
1.83620000315798E-08 |
| Stage1-vs-Stage2 |
8.511200E-01 |
| Stage1-vs-Stage3 |
3.269400E-01 |
| Stage1-vs-Stage4 |
8.515500E-02 |
| Stage2-vs-Stage3 |
6.149000E-01 |
| Stage2-vs-Stage4 |
2.977600E-01 |
| Stage3-vs-Stage4 |
5.479600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.68749508495148E-11 |
| Normal-vs-AfricanAmerican |
2.432200E-01 |
| Normal-vs-Asian |
8.541300E-03 |
| Caucasian-vs-AfricanAmerican |
1.558680E-03 |
| Caucasian-vs-Asian |
1.376510E-04 |
| AfricanAmerican-vs-Asian |
3.156200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.02929944754283E-10 |
| Normal-vs-Female |
1.56107000000016E-05 |
| Male-vs-Female |
1.166820E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.837940E-02 |
| Normal-vs-Age(41-60Yrs) |
8.03790000003524E-07 |
| Normal-vs-Age(61-80Yrs) |
6.91640000827221E-09 |
| Normal-vs-Age(81-100Yrs) |
7.773700E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.562400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.583800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.965000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.274000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.735580E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.242000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.869800E-01 |
| Normal-vs-Grade 2 |
1.36149999996338E-06 |
| Normal-vs-Grade 3 |
7.74419994797881E-09 |
| Normal-vs-Grade 4 |
1.11040000527751E-08 |
| Grade 1-vs-Grade 2 |
3.512400E-02 |
| Grade 1-vs-Grade 3 |
9.799500E-03 |
| Grade 1-vs-Grade 4 |
1.580860E-03 |
| Grade 2-vs-Grade 3 |
2.149600E-01 |
| Grade 2-vs-Grade 4 |
2.993600E-02 |
| Grade 3-vs-Grade 4 |
2.008400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.31889999999135E-06 |
| Normal-vs-ccB subtype |
2.38659999984847E-07 |
| ccA subtype-vs-ccB subtype |
2.749200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.46910000053957E-07 |
| Normal-vs-N1 |
2.806000E-02 |
| N0-vs-N1 |
6.271400E-01 |
|
|
